Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2033

RNA Targeting Small Molecules Therapeutics Market 2024 – By Product (Antisense Oligonucleotides (ASOS), Small Interfering RNA (SIRNA)), By Therapeutic Indication (Musculoskeletal Disorder, Neurodegenerative Diseases, Cardiovascular Disease, Genito-Urinary, Therapeutic Indications), By End User (Hospitals, Research Laboratories, Pharmaceutical And Biotechnology Companies, Other End-Users), And By Region, Opportunities And Strategies – Global Forecast To 2033

RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2033

Starting Price : $5000.00 $3500.00 | Pages : 295 | Published : May 2024 | | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

RNA Targeting Small Molecules Therapeutics Market Definition

RNA (ribonucleic acid) targeting small molecule therapeutics are a class of pharmaceutical compounds designed to specifically interact with RNA molecules within cells, modulating their function and activity to treat various diseases. RNA molecules play critical roles in gene expression, protein synthesis and cellular regulation and dysregulation of RNA function is implicated in numerous diseases, including cancer, genetic disorders, viral infections and neurodegenerative diseases.

The RNA targeting small molecule therapeutics market consists of sales of RNA targeting small molecule therapeutics by entities (organizations, sole traders or partnerships) that are engaged in the research, development and commercialization of therapeutic agents designed to interact with RNA through various mechanisms. These offerings include mRNA Translation modulators that affect the process by which messenger RNA (mRNA) is translated into proteins, RNA Splicing modifiers that alter the way in which RNA is spliced and various segments are joined together to form mature mRNA, Direct RNA Targeting molecules that bind directly to RNA to affect its function and other innovative approaches to RNA targeting.

Book your 30 minutes free consultation with our research experts

Contact Us

RNA Targeting Small Molecules Therapeutics Market Size

The global RNA targeting small molecule therapeutics market reached a value of nearly $4,776.0 million in 2023, having grown at a compound annual growth rate (CAGR) of 28.8% since 2018. The market is expected to grow from $4,776.0 million in 2023 to $17,327.6 million in 2028 at a rate of 29.4%. The market is then expected to grow at a CAGR of 28.3% from 2028 and reach $60,229.5 million in 2033.  

Growth in the historic period resulted from the increasing incidence of neurological disorders, growing interest in personalized medicine and government initiatives for research and development in healthcare. Factors that negatively affected growth in the historic period were complexity of RNA-based drug discovery.

Going forward, increasing government funding for RNA research, rising prevalence of cancer and increasing incidence of genetic disorders will drive the growth. Factor that could hinder the growth of the RNA targeting small molecule therapeutics market in the future include high cost of drug development.  

RNA Targeting Small Molecules Therapeutics Market Drivers

The key drivers of the RNA targeting small molecules therapeutics market include:

Increasing Government Funding For RNA Research

The increasing government funding for RNA research is expected to contribute to the growth of the RNA targeting small molecule therapeutics market during the forecast period. Government funding for RNA research refers to the financial support provided by governmental agencies to facilitate scientific investigations into the roles, functions and potential applications of RNA molecules in various fields such as medicine and fundamental biological research. Increasing government funding for RNA research is driven by recognition of its potential to revolutionize healthcare, biotechnology and understanding fundamental biological processes. Government funding for RNA research facilitates RNA targeting small molecule therapeutics by supporting basic research, technology development and collaborative initiatives, thereby accelerating the identification and optimization of small molecules for therapeutic intervention. For instance, in February 2024, according to the U.S. National Science Foundation, a US-based independent federal agency, National Science Foundation (NSF) and National Human Genome Research Institute (NHGRI) awarded $12.7 million to nine research teams for exploring RNA's potential in diverse biotech applications, from crop disease prevention to cancer therapies. Therefore, the increasing government funding for RNA research will drive the RNA targeting small molecule therapeutics market.

RNA Targeting Small Molecules Therapeutics Market Restraints

The key restraints on the RNA targeting small molecules therapeutics market include:

High Cost Of Drug Development

The high cost of drug development is expected to hamper the growth of the RNA targeting small molecule therapeutics market in the forecast period. Drug development is the process of discovering, designing and bringing pharmaceutical products to market to address medical needs. The high cost of drug development can hinder RNA targeting small molecule therapeutics by limiting research funding and industry investment, thereby impeding progress in identifying effective therapeutics. For instance, in February 2023, the cost of FDA drug approvals for a new drug entering the market in 2022 has risen to $2 million. Therefore, the high cost of drug development can hamper the RNA targeting small molecule therapeutics market going forward.

RNA Targeting Small Molecules Therapeutics Market Trends

Major trends shaping the RNA targeting small molecules therapeutics market include:

Strategic Collaboration Fueling RNA Targeting Small Molecules Therapeutics

Companies operating in the RNA targeting small molecule therapeutics market are focusing on strategic collaborations to enhance their research and development efforts. Strategic collaboration enhances RNA targeting small molecule therapeutics by pooling expertise and resources for accelerated innovation. For instance, in January 2024, Remix Therapeutics, a US-based clinical-stage biotechnology company specializing in small molecule therapies targeting RNA processing, collaborated with F. Hoffmann-La Roche AG, a Switzerland-based biopharmaceutical company. The strategic collaboration between Remix Therapeutics and Roche signifies a significant advancement in the field of RNA modulation for drug discovery. This partnership, focusing on discovering and developing small molecule therapeutics with the REMaster drug discovery platform, marks a notable progression in RNA modulation for drug discovery, combining Remix Therapeutics' platform with Roche's global expertise. It holds the potential for innovative solutions to address medical gaps and transform therapeutic strategies.

Key Players Embrace Startup Solutions In RNA Targeting Small Molecules Therapeutics

Companies in the RNA targeting small molecule therapeutics market are focusing on innovative startup solutions to optimize drug design and enhance RNA-targeted therapeutic development. These solutions facilitate target identification, molecular design and predictive modeling for efficacy and safety to contribute to the health and well-being of all people worldwide. For instance, in February 2024, AION Labs, an Israel-based venture hub for drug discovery and BioMed X, a Germany-based research institute, launched a global call for applications to identify computational biologists, biomedical scientists and inventors to form a new startup at AION Labs. It focuses on the development of an artificial intelligence (AI) and machine learning (ML) computational platform to identify functional regions in RNA that can be targeted with small molecules. RNA has traditionally been deemed unsuitable for small-molecule binding.

Opportunities And Recommendations In The RNA Targeting Small Molecules Therapeutics Market

Opportunities – The top opportunities in the RNA targeting small molecule therapeutics market segmented by type will arise in the ASO segment, which will gain $8,384.0 million of global annual sales by 2028. The top opportunities in the RNA targeting small molecule therapeutics market segmented by therapeutic indication will arise in the musculoskeletal disorder segment, which will gain $8,409.9 million of global annual sales by 2028. The top opportunities in the RNA targeting small molecule therapeutics market segmented by end-user will arise in the pharmaceutical and biotechnology companies segment, which will gain $7,089.1 million of global annual sales by 2028. The RNA targeting small molecule therapeutics market size will gain the most in the USA at $4,632.5 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends RNA targeting small molecules therapeutics companies to focus on ai integration for enhanced drug discovery, focus on advancing RNA degrader therapeutics, focus on MRNA small molecule drug discovery, focus on SIRNA market segment, focus on musculoskeletal disorder and cardiovascular disease segments, expand in emerging markets, continue to focus on developed markets, focus on strategic collaborations for accelerated innovation, provide competitively priced offerings, continue to use B2B promotions, focus on pharmaceutical and biotechnology companies and research laboratories and focus on cancer patients.

RNA Targeting Small Molecules Therapeutics Market Segmentation

The RNA targeting small molecules therapeutics market is segmented by product, by therapeutic indication and by end-user.

By Product –
The RNA targeting small molecules therapeutics market is segmented by product into:
    • a) Antisense Oligonucleotides (ASOs)
    • b) Small Interfering RNA (siRNA)
The antisense oligonucleotides (ASOs) market was the largest segment of the RNA targeting small molecule therapeutics market segmented by type, accounting for 68.8% or $3,286.0 million of the total in 2023. Going forward, the siRNA is expected to be the fastest growing segment in the RNA targeting small molecule therapeutics market segmented by type, at a CAGR of 30.6% during 2023-2028.

By Therapeutic Indication –
The RNA targeting small molecules therapeutics market is segmented by therapeutic indication into:
    • a) Musculoskeletal Disorder
    • b) neurodegenerative diseases
    • c) cardiovascular disease
    • d) Genito-Urinary
    • e) Therapeutic Indications
The musculoskeletal disorder market was the largest segment of the RNA targeting small molecule therapeutics market segmented by therapeutic indication, accounting for 61.7% or $2,947.8 million of the total in 2023. Going forward, the cardiovascular disease segment is expected to be the fastest growing segment in the RNA targeting small molecule therapeutics market segmented by therapeutic indication, at a CAGR of 32.6% during 2023-2028.

By End Users –
The RNA targeting small molecules therapeutics market is segmented by end users into:
    • a) Hospitals
    • b) Research Laboratories
    • c) Pharmaceutical and Biotechnology Companies
    • d) Other End-Users
The pharmaceutical and biotechnology companies market was the largest segment of the RNA targeting small molecule therapeutics market segmented by end-user, accounting for 55.1% or $2,630.3 million of the total in 2023. Going forward, the research laboratories segment is expected to be the fastest growing segment in the RNA targeting small molecule therapeutics market segmented by end-user, at a CAGR of 30.3% during 2023-2028.

By Geography - The RNA targeting small molecules therapeutics market is segmented by geography into:
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      • • Canada
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      • • Italy
      • • Spain
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the RNA targeting small molecule therapeutics market, accounting for 52.8% or $2,522.7 million of the total in 2023. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the RNA targeting small molecule therapeutics market will be South America and Eastern Europe where growth will be at CAGRs of 35.0% and 31.6% respectively. These will be followed by Asia Pacific and Western Europe where the markets are expected to grow at CAGRs of 30.6% and 28.9% respectively.

RNA Targeting Small Molecules Therapeutics Market Competitive Landscape

Major Competitors are:

  • Ionis Pharmaceuticals
  • Alnylam Pharmaceuticals
  • Sarepta Therapeutics
  • Jazz Pharmaceuticals
  • Novartis

    • Other Competitors Include:

  • NS Pharma
  • Arrakis Therapeutics
  • PTC Therapeutics
  • Anima Biotech Inc.
  • Ribometrix.
  • Daiichi Sankyo
  • Veritas In Silico Inc
  • RaQualia Pharma
  • Takeda Pharmaceutical Company Limited
  • HitGen Inc.
  • Hutchison China MediTech Limited
  • Zai Lab Ltd
  • Innovent Biologics
  • JW Therapeutics
  • Otsuka Pharmaceutical Co., Ltd
  • BioMed X GmbH
  • Depixus SAS
  • Bayer AG
  • Evotec SE
  • Storm Therapeutics
  • MiNA Therapeutics
  • Artios Pharma
  • Accent Therapeutics
  • Selvita S.A.
  • OncoArendi Therapeutics S.A.
  • Mabion S.A.
  • Biomed Lublin S.A.
  • Celon Pharma S.A.
  • Expansion Therapeutics
  • Sequence Bio
  • Serna Bio (previously Ladder Therapeutics).
  • EMS Pharma
  • Aspen Pharmacare
  • Chiesi Farmacêutica
  • Biolab Pharma
  • Eurofarma Laboratórios
  • Igenomix
  • NewBridge Pharmaceutical
  • Seegene
  • Julphar
  • Aspen Pharmacare Holdings Ltd
  • Pharco Pharmaceuticals Inc.
  • Egyptian International Pharmaceutical Industries Company

      • Table Of Contents

      1Executive Summary

      1.1 RNA Targeting Small Molecule Therapeutics – Market Attractiveness And Macro economic Landscape

      2 Table Of Contents

      3 List Of Tables

      4 List Of Figures

      5 Report Structure

      6 Market Characteristics

      6.1 General Market Definition

      6.2 Summary

      6.3 RNA Targeting Small Molecules Therapeutics Market Definition And Segmentations

      6.4 Market Segmentation By Product

      6.4.1 Antisense Oligonucleotides (ASOs)

      6.4.2 siRNA

      6.5 Market Segmentation By Therapeutic Indication

      6.5.1 Musculoskeletal Disorder

      6.5.2 Neurodegenerative Diseases

      6.5.3 Cardiovascular disease

      6.5.4 Genito-Urinary

      6.5.5 Other Therapeutic Indications

      6.6 Market Segmentation By End-User

      6.6.1 Hospitals

      6.6.2 Research Laboratories

      6.6.3 Pharmaceutical And Biotechnology Companies

      6.6.4 Other End-Users

      7 Major Market Trends

      7.1 Strategic Collaboration Fueling RNA Targeting Small Molecules Therapeutics

      7.2 Key Players Embrace Startup Solutions In RNA Targeting Small Molecules Therapeutics

      7.3 Use Of Artificial Intelligence (AI) To Enhance Efficiency Of RNA Targeting Small Molecules During Drug Discovery

      7.4 Partnerships Driving Innovation In RNA Targeting Small Molecules Therapeutics

      7.5 Focus On Advancement In RNA Degrader Therapeutics Targeting For Various Medical Domains

      7.6 Increased Focus On mRNA Small Molecule Drug Discovery

      7.7 Development Of RNA Modulatory Drugs For Treating Neurological Diseases

      8 RNA Targeting Small Molecules Therapeutics Market - Macro Economic Scenario

      8.1 COVID-19 Impact On The RNA Targeting Small Molecules Therapeutics Market

      8.2 Impact Of The War In Ukraine On The RNA Targeting Small Molecules Therapeutics Market

      8.3 Impact Of High Inflation On The RNA Targeting Small Molecules Therapeutics Market

      9 Global Market Size and Growth

      9.1 Market Size

      9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)

      9.2.1 Market Drivers 2018 – 2023

      9.2.2 Market Restraints 2018 – 2023

      9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)

      9.3.1 Market Drivers 2023 – 2028

      9.3.2 Market Restraints 2023 – 2028

      10 Global RNA Targeting Small Molecules Therapeutics Market Segmentation

      10.1 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.2 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.3 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      11 RNA Targeting Small Molecules Therapeutics Market, Regional and Country Analysis

      11.1 Global RNA Targeting Small Molecules Therapeutics Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      11.2 Global RNA Targeting Small Molecules Therapeutics Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12 Asia-Pacific Market

      12.1 Summary

      12.1.1 Market Overview

      12.1.2 Region Information

      12.1.3 Market Information

      12.1.4 Background Information

      12.1.5 Government Initiatives

      12.1.6 Regulations

      12.1.7 Regulatory Bodies

      12.1.8 Major Associations

      12.1.9 Taxes Levied

      12.1.10 Corporate Tax Structure

      12.1.11 Investments

      12.1.12 Major Companies

      12.2 Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.3 Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.4 Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.5 Asia-Pacific RNA targeting Small Molecules Therapeutics Market: Country Analysis

      12.6 China Market

      12.7 Summary

      12.7.1 Market Overview

      12.7.2 Country Information

      12.7.3 Market Information

      12.7.4 Background Information

      12.7.5 Government Initiatives

      12.7.6 Regulations

      12.7.7 Regulatory Bodies

      12.7.8 Major Associations

      12.7.9 Taxes Levied

      12.7.10 Corporate Tax Structure

      12.7.11 Investments

      12.7.12 Major Companies

      12.8 China RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.9 China RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.10 China RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.11 India Market

      12.12 India RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.13 India RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.14 India RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.15 Japan Market

      12.16 Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.17 Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.18 Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.19 Australia Market

      12.20 Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.21 Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.22 Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.23 Indonesia Market

      12.24 Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.25 Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.26 Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.27 South Korea Market

      12.28 South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.29 South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.30 South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13 Western Europe Market

      13.1 Summary

      13.1.1 Market Overview

      13.1.2 Region Information

      13.1.3 Market Information

      13.1.4 Background Information

      13.1.5 Government Initiatives

      13.1.6 Regulations

      13.1.7 Regulatory Bodies

      13.1.8 Major Associations

      13.1.9 Taxes Levied

      13.1.10 Corporate Tax Structure

      13.1.11 Investments

      13.1.12 Major Companies

      13.2 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.3 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.4 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.5 Western Europe RNA Targeting Small Molecules Therapeutics Market: Country Analysis

      13.6 UK Market

      13.7 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.8 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.9 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.10 Germany Market

      13.11 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.12 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.13 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.14 France Market

      13.15 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.16 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.17 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.18 Italy Market

      13.19 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.20 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.21 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.22 Spain Market

      13.23 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.24 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.25 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14 Eastern Europe Market

      14.1 Summary

      14.1.1 Market Overview

      14.1.2 Region Information

      14.1.3 Market Information

      14.1.4 Background Information

      14.1.5 Government Initiatives

      14.1.6 Regulations

      14.1.7 Regulatory Bodies

      14.1.8 Major Associations

      14.1.9 Taxes Levied

      14.1.10 Corporate Tax Structure

      14.1.11 Major Companies

      14.2 Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.3 Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.4 Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.5 Eastern Europe RNA targeting Small Molecules Therapeutics Market: Country Analysis

      14.6 Russia Market

      14.7 Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.8 Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.9 Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15 North America Market

      15.1 Summary

      15.1.1 Market Overview

      15.1.2 Region Information

      15.1.3 Market Information

      15.1.4 Background Information

      15.1.5 Government Initiatives

      15.1.6 Regulations

      15.1.7 Regulatory Bodies

      15.1.8 Major Associations

      15.1.9 Taxes Levied

      15.1.10 Corporate Tax Structure

      15.1.11 Investments

      15.1.12 Major Companies

      15.2 North America RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.3 North America RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.4 North America RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.5 North America RNA targeting Small Molecules Therapeutics Market: Country Analysis

      15.6 USA Market

      15.7 Summary

      15.7.1 Market Overview

      15.7.2 Country Information

      15.7.3 Market Information

      15.7.4 Background Information

      15.7.5 Government Initiatives

      15.7.6 Regulations

      15.7.7 Regulatory Bodies

      15.7.8 Major Associations

      15.7.9 Taxes Levied

      15.7.10 Corporate Tax Structure

      15.7.11 Investments

      15.7.12 Major Companies

      15.8 USA RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.9 USA RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.10 USA RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.11 Canada Market

      15.12 Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.13 Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.14 Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16 South America Market

      16.1 Summary

      16.1.1 Market Overview

      16.1.2 Region Information

      16.1.3 Market Information

      16.1.4 Background Information

      16.1.5 Government Initiatives

      16.1.6 Regulations

      16.1.7 Regulatory Bodies

      16.1.8 Major Associations

      16.1.9 Taxes Levied

      16.1.10 Corporate Tax Structure

      16.1.11 Investments

      16.1.12 Major Companies

      16.2 South America RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.3 South America RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.4 South America RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.5 South America RNA targeting Small Molecules Therapeutics Market: Country Analysis

      16.6 Brazil Market

      16.7 Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.8 Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.9 Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17 Middle East Market

      17.1 Summary

      17.1.1 Market Overview

      17.1.2 Region Information

      17.1.3 Market Information

      17.1.4 Background Information

      17.1.5 Government Initiatives

      17.1.6 Regulations

      17.1.7 Regulatory Bodies

      17.1.8 Major Associations

      17.1.9 Taxes Levied

      17.1.10 Corporate Tax Structure

      17.1.11 Investments

      17.1.12 Major Companies

      17.2 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17.3 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17.4 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18 Africa Market

      18.1 Summary

      18.2 Market Overview

      18.2.1 Region Information

      18.2.2 Market Information

      18.2.3 Background Information

      18.2.4 Government Initiatives

      18.2.5 Regulations

      18.2.6 Regulatory Bodies

      18.2.7 Major Associations

      18.2.8 Taxes Levied

      18.2.9 Corporate Tax Structure

      18.2.10 Major Companies

      18.3 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18.4 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18.5 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      19 Competitive Landscape And Company Profiles

      19.1 Company Profiles

      19.2 Ionis Pharmaceuticals

      19.2.1 Company Overview

      19.2.2 Products And Services

      19.2.3 Business Strategy

      19.2.4 Financial performance

      19.3 Alnylam Pharmaceuticals

      19.3.1 Company Overview

      19.3.2 Products And Services

      19.3.3 Business Strategy

      19.3.4 Financial performance

      19.4 Sarepta Therapeutics

      19.4.1 Company Overview

      19.4.2 Products And Services

      19.4.3 Business Strategy

      19.4.4 Financial performance

      19.5 Jazz Pharmaceuticals

      19.5.1 Company Overview

      19.5.2 Products And Services

      19.5.3 Financial performance

      19.6 Novartis

      19.6.1 Company Overview

      19.6.2 Products And Services

      19.6.3 Business Strategy

      19.6.4 Financial performance

      20 RNA Targeting Small Molecules Therapeutics Market Other Major And Innovative Companies

      20.1 NS Pharma

      20.1.1 Company Overview

      20.1.2 Products And Services

      20.2 Arrakis Therapeutics

      20.2.1 Company Overview

      20.2.2 Products And Services

      20.3 PTC Therapeutics

      20.3.1 Company Overview

      20.3.2 Products And Services

      20.4 Anima Biotech Inc.

      20.4.1 Company Overview

      20.4.2 Products And Services

      20.5 Ribometrix

      20.5.1 Company Overview

      20.5.2 Products And Services

      20.6 Skyhawk Therapeutics Inc.

      20.6.1 Company Overview

      20.6.2 Products And Services

      20.7 STORM Therapeutics Ltd.

      20.7.1 Company Overview

      20.7.2 Products And Services

      20.8 Accent Therapeutics

      20.8.1 Company Overview

      20.8.2 Products And Services

      20.9 Promega Corporation

      20.9.1 Company Overview

      20.9.2 Products And Services

      20.10 Bayer AG

      20.10.1 Company Overview

      20.10.2 Products And Services

      20.11 Arrowhead Pharmaceuticals Inc.

      20.11.1 Company Overview

      20.11.2 Products And Services

      20.12 Abivax SA

      20.12.1 Company Overview

      20.12.2 Products And Services

      20.13 AC Immune SA

      20.13.1 Company Overview

      20.13.2 Products And Services

      20.14 Remix Therapeutics

      20.14.1 Company Overview

      20.14.2 Products And Services

      20.15 858 Therapeutics

      20.15.1 Company Overview

      20.15.2 Products And Services

      21 Competitive Benchmarking

      22 Competitive Dashboard

      23 Key Mergers And Acquisitions

      23.1 Novo Nordisk Acquire DiceRNA Pharmaceuticals

      23.2 Sanofi's Acquired Translate Bio

      24 Opportunities And Strategies

      24.1 Global RNA Targeting Small Molecules Therapeutics Market In 2028 – Countries Type Most New Opportunities

      24.2 Global RNA Targeting Small Molecules Therapeutics Market In 2028 – Segments Type Most New Opportunities

      24.3 Global RNA Targeting Small Molecules Therapeutics Market In 2028 – Growth Strategies

      24.3.1 Market Trend Based Strategies

      24.3.2 Competitor Strategies

      25 RNA Targeting Small Molecules Therapeutics Market, Conclusions And Recommendations

      25.1 Conclusions

      25.2 Recommendations

      25.2.1 Product

      25.2.2 Place

      25.2.3 Price

      25.2.4 Promotion

      25.2.5 People

      26 Appendix

      26.1 Geographies Covered

      26.2 Market Data Sources

      26.3 Research Methodology

      26.4 Currencies

      26.5 The Business Research Company

      26.6 Copyright and Disclaimer

    List Of Tables

      Table 1: Global RNA Targeting Small Molecules Therapeutics Market, Historic, 2018 – 2023, $ Million  
    • Table 2: Global RNA Targeting Small Molecules Therapeutics Market, Forecast, 2023 – 2028, 2033F, $ Million  
    • Table 3: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 4: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 5: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 6: Global RNA Targeting Small Molecules Therapeutics Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 7: Global RNA Targeting Small Molecules Therapeutics Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 8: Asia-Pacific GDP Per Capita, By Country, 2018-2023, $  
    • Table 9:  Asia-Pacific Population, By Country, 2018-2028, Millions  
    • Table 10: Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 11: Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 12: Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 13: China GDP Per Capita, 2018-2023, $  
    • Table 14:  China Population, 2018-2028, Millions  
    • Table 15: China RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 16: China RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 17: China RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 18: India RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 19: India RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 20: India RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 21: Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 22: Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 23: Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 24: Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 25: Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 26: Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 27: Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 28: Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 29: Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 30: South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 31: South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 32: South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 33: Western Europe GDP Per Capita, By Country, 2018-2023, $  
    • Table 34:  Western Europe Population, By Country, 2018-2028, Millions  
    • Table 35: Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 36: Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 37: Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 38: UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 39: UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 40: UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 41: Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 42: Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 43: Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 44: France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 45: France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 46: France RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 47: Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 48: Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 49: Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 50: Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 51: Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 52: Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 53: Eastern Europe GDP Per Capita, By Country, 2018-2023, $  
    • Table 54:  Eastern Europe Population, By Country, 2018-2028, Millions  
    • Table 55: Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 56: Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 57: Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 58: Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 59: Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 60: Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 61: North America GDP Per Capita, By Country, 2018-2023, $  
    • Table 62:  North America Population, By Country, 2018-2028, Millions  
    • Table 63: North America RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 64: North America RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 65: North America RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 66: USA GDP Per Capita, 2018-2023, $  
    • Table 67:  USA Population, 2018-2028, Millions  
    • Table 68: USA RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 69: USA RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 70: USA RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 71: Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 72: Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 73: Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 74: South America GDP Per Capita, By Country, 2018-2023, $  
    • Table 75:  South America Population, By Country, 2018-2028, Millions  
    • Table 76: South America RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 77: South America RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 78: South America RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 79: Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 80: Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 81: Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 82: Middle East GDP Per Capita, By Country, 2018-2023, $  
    • Table 83:  Middle East Population, By Country, 2018-2028, Millions  
    • Table 84: Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 85: Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 86: Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 87: Africa GDP Per Capita, By Country, 2018-2023, $  
    • Table 88:  Africa Population, By Country, 2018-2028, Millions  
    • Table 89: Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 90: Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 91: Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Table 92: Global RNA Targeting Small Molecules Therapeutics Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)  
    • Table 93: Ionis Pharmaceuticals – Financial Overview, 2018 – 2022, $ Billion  
    • Table 94: Alnylam Pharmaceuticals – Financial Overview, 2018 – 2022, $ Billion  
    • Table 95: Sarepta Therapeutics – Financial Overview, 2018 – 2022, $ Billion  
    • Table 96: Jazz Pharmaceuticals – Financial Overview, 2018 – 2022, $ Billion  
    • Table 97: Novartis – Financial Overview, 2018 – 2022, $ Billion  
    • Table 98: RNA Targeting Small Molecules Therapeutics Market, Competitive Benchmarking (In USD Millions)  
    • Table 99: RNA Targeting Small Molecules Therapeutics Market, Competitive Dashboard  
    • Table 100: Global RNA Targeting Small Molecules Therapeutics Market Size Gain ($ Million), 2023 – 2028, By Country  
    • Table 101: Global RNA Targeting Small Molecules Therapeutics Market Size Gain ($ Million), Segmentation By Type, 2023 – 2028  
    • Table 102: Global RNA Targeting Small Molecules Therapeutics Market Size Gain ($ Million), Segmentation By Therapeutic Indication, 2023 – 2028  
    • Table 103: Global RNA Targeting Small Molecules Therapeutics Market Size Gain ($ Million), Segmentation By End-User, 2023 – 2028  
    • Table 104: RNA Targeting Small Molecules Therapeutics Market Data Sources

    List Of Figures

      Figure 1: Global RNA Targeting Small Molecules Therapeutics Market Segmentation By Product  
    • Figure 2: Global RNA Targeting Small Molecules Therapeutics Market Segmentation By Therapeutic Indication  
    • Figure 3: Global RNA Targeting Small Molecules Therapeutics Market Segmentation By End-User  
    • Figure 4: Global RNA Targeting Small Molecules Therapeutics Market, Historic, 2018 – 2023, $ Million  
    • Figure 5: Global RNA Targeting Small Molecules Therapeutics Market, Forecast, 2023 – 2028, 2033F, $ Million  
    • Figure 6: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 7: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 8: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 9: Global RNA Targeting Small Molecules Therapeutics Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 10: Global RNA Targeting Small Molecules Therapeutics Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 11: Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 12: Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 13: Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 14: China RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 15: China RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 16: China RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 17: India RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 18: India RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 19: India RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 20: Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 21: Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 22: Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 23: Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 24: Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 25: Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 26: Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 27: Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 28: Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 29: South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 30: South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 31: South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 32: Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 33: Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 34: Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 35: UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 36: UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 37: UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 38: Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 39: Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 40: Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 41: France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 42: France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 43: France RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 44: Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 45: Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 46: Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 47: Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 48: Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 49: Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 50: Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 51: Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 52: Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 53: Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 54: Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 55: Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 56: North America RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 57: North America RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 58: North America RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 59: USA RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 60: USA RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 61: USA RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 62: Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 63: Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 64: Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 65: South America RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 66: South America RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 67: South America RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 68: Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 69: Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 70: Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 71: Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 72: Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 73: Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 74: Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 75: Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 76: Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million  
    • Figure 77: Global RNA Targeting Small Molecules Therapeutics Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)  
    • Figure 78: Ionis Pharmaceuticals – Financial Overview, 2018 – 2022, $ Billion  
    • Figure 79: Alnylam Pharmaceuticals – Financial Overview, 2018 – 2022, $ Billion  
    • Figure 80: Sarepta Therapeutics – Financial Overview, 2018 – 2022, $ Billion  
    • Figure 81: Jazz Pharmaceuticals – Financial Overview, 2018 – 2022, $ Billion  
    • Figure 82: Novartis – Financial Overview, 2018 – 2022, $ Billion  
    • Figure 83: Geographic Regions Covered

    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

    Read More

    The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

    Read More

    The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

    Read More

    Global Anticoagulants Market 2022 – Market Opportunities And Strategies

    Read More

    Latest Digestive Health Supplements Market Growth Study 2022-2026 By The Business Research Company

    Read More

    The Business Research Company offers the nucleic acid based gene therapy market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the radiopharmaceuticals market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the pegfilgrastim biosimilars market market research report 2022 with industry size, share, segments and market growth

    Read More

    CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Enzymes Global Market Report 2024 – By Product Type (Asparaginase, Lipase, Protease, Nattokinase, Chitinase, Serratiopeptidase, Collagenase, Ligase, Other Products), By Application (Leukemia, Stomach Disorders, Antitumor, Skin Ulcers, Gaucher Disease, Fabry Disease, Other Applications), By End User (Drug Manufacturers, Hospitals, Private Clinics, Research Laboratories) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Cellular Immunotherapy Global Market Report 2024 – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications ) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Oral Biologics & Biosimilar Drugs Global Market Report 2024 – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn's Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies, Other Molecule Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Digestive Enzymes Global Market Report 2024 – By Enzyme Type (Carbohydrates, Protease, Lipase, Other Enzyme Types), By Origin (Animal, Fungi, Microbial, Plant), By Application (Indigestion, Chronic Pancreatitis, Irritable Bowel Syndrome, Other Applications), By Distribution Channel (Retail Stores, Online Stores) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Oncology Biosimilars Global Market Report 2024 – By Drug Type (Monoclonal Antibody, Immunomodulators, Hematopoietic Agents, Granulocyte Colony-Stimulating Factor (G-CSF)), By Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, Other Cancer Types), By Distribution Type (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Corticosteroids Global Market Report 2024 – By Product (Glucocorticoids, Mineralocorticoids), By Application (Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications), By End User (Hospitals, Clinics, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report